Article
The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection
29 Nov 2016
Abstract excerpt
Lyme borreliosis (LB) is the most prevalent arthropod-borne infectious disease in North America and many countries of the temperate Northern Hemisphere. It is associated with local and systemic manifestations and has persistent post-treatment health complications in some individuals. Innate and acquired immunity-related inflammation is likely to play a critical role in both host defense against Borrelia...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
